0:00
32:38
This month’s show features a guest author discussing, Dr. Yusuf Yazici, discussing his team’s efforts to create a drug treatment for osteoarthritis. The study was published in the American College of Rheumatology’s journal, Arthritis & Rheumatology.
Otros episodios de "ACR on Air"
26. Vasculitis Guidelines Miniseries - Part 3
23:28
In this episode of ACR on Air, we reach the final installment of our vasculitis guideline miniseries. Dr. Hausmann is once again joined by Dr. Sharon Chung, lead author of the 2021 ACR/VF guidelines for managing systemic vasculitis, to discuss Polyarteritis Nodosa (PAN). Dr. Chung weighs in on CTA over MRA for abdominal vascular imaging, and blind biopsy. Dr. Hausmann and Dr. Chung examine various patient scenarios for PAN symptoms and why they would meet the criteria for data testing.25. Vasculitis Guidelines Miniseries - Part 2
23:13
In this episode of ACR on Air, we continue into part two of our Vasculitis miniseries with Dr. Sharon Chung, lead author of the 2021 ACR/VF guidelines for managing systemic vasculitis. Dr. Chung addresses how the guidelines were developed, the use of use temporal artery biopsy, and the on-going challenges with treating Takayasu’s arteritis. She also highlights the success of non-invasive ultrasound techniques in Europe for diagnosing Giant Cell Arteritis (GCA) and discusses the treatment approaches for GCA.No te pierdas ningún episodio de “ACR on Air”. Síguelo en la aplicación gratuita de GetPodcast.
24. Vasculitis Guidelines Miniseries - Part 1
31:00
In this episode of ACR on Air we begin the first entry in our Vasculitis miniseries with Dr. Sharon Chung, where we take a detailed examination of the 2021 ACR/VF guidelines for managing systemic vasculitis. In part one of the series Dr. Chung will discuss the importance and creation of the guidelines along with the impact the author's hope to achieve. We then dive into the recommendations for ANCA-associated vasculitis, including: GPA, EGPA and MPA. We'll address controversial questions for treatment and the impacts that arise for COVID-19 vaccinations.23. COVID-19 Updates: Vaccine 3rd Doses, Antibody Testing & Real-World Data
33:53
It’s been seven months since the ACR released its COVID-19 Vaccine Clinical Guidance for Patients with Rheumatic and Musculoskeletal Diseases, and we continue to learn more about navigating COVID-19 in rheumatology patients. Some real-world data has become available on patient outcomes. The FDA has issued an EUA for 3rd doses of an available mRNA vaccine in certain immunocompromised patients. Antibody testing continues to be heavily debated. And monoclonal antibody treatment has received an EUA to be used as a prophylaxis measure in patients at high risk for developing severe COVID-19. Dr. Jeff Curtis, Chair of the ACR COVID-19 Vaccine Guidance Task Force, joins us to discuss these developments, updated task force recommendations, and more.22. The Impact of Diet on Rheumatic Conditions
58:18
On episode 21, we discussed alternative therapies that providers and patients can consider to support treatment plans for rheumatic diseases. On this episode, Dr. Monica Guma joins the show to talk about how diet may impact these conditions, positively or negatively. The host, Dr. Guma nor the ACR suggest that patients with rheumatic conditions forgo traditional treatment plans recommended by trained rheumatologists and rheumatology health professionals. Patients should continue to see their rheumatologist to discuss complements to their treatment plan.21. Use of Complementary Alternative Therapies in Rheumatic Care
57:52
So, what are we talking about today? A topic that comes up often between providers and patients—alternative and integrative therapies to help treat rheumatic conditions. Dr. Chenchen Wang joins the show to talk about a few of the popular therapies available for common conditions, address a few myths, and offer insight on how rheumatologists can support patients interested in these alternative options. While we are taking time to discuss this popular topic, the host, Dr. Wang nor the ACR are suggesting that patients with rheumatic conditions forgo traditional treatment plans recommended by trained rheumatologists and rheumatology health professionals. Patients should continue to see their rheumatologist for updates or additions to their treatment plan.20. Looking Back on a Year of Telemedicine During COVID-19
45:51
This month, our host takes a look back on the telemedicine journey many health care providers and patients navigated in 2020. Dr. Christine Peoples and Dr. Aruni Jayatilleke join as guests sharing their experiences and tips on digitally treating patients with rheumatic diseases.19. ACR COVID-19 Vaccine Guidance Recommends Vaccination, Addresses Immunosuppressant Drugs & Patient Concerns
40:38
This show is a special one and covers a topic that so many of you have been asking about! The American College of Rheumatology just released its guidance on the COVID-19 vaccine for patients with rheumatic diseases, and we have the lead author, Dr. Jeff Curtis, on with our host to discuss the research and recommendations. Throughout the show, you will hear Dr. Curtis the ACR’s recommendation that all patients with rheumatic diseases should get the vaccine and that it does not matter which one you get—just make sure your second dose is by the same brand. Bottom line: get whichever one is available to you as soon as you can get it. They also discuss the process of developing the ACR guidance, the experts involved including epidemiologists, rheumatologists, and infectious disease clinicians; and how they plan to keep the document updated. And finally, they discuss the safety and efficacy of the vaccines despite how rapidly they were developed, the low risk of disease flares, and the importance of ongoing research on this topic. This is the episode you want to listen to NOW!18. Advocacy in Rheumatology (Jan. 19, 2021)
43:44
This month’s show focuses on advocacy in the rheumatology space. Our host chats with Lennie Shewmaker McDaniel, director of congressional affairs for the ACR; and Amanda Grimm Wiegrefe, the ACR’s director of regulatory affairs about advocacy wins and losses for 2020, the upcoming priorities for 2021, and how listeners can get involved.
Descubre los mejores podcast en la aplicación gratuita de GetPodcast.
Suscríbete a tus podcast favoritos, escucha episodios cuando estés sin conexión y déjate sorprender por las recomendaciones personalizadas.
© radio.de GmbH 2022